|
Name |
paecilin G
|
Molecular Formula | C34H38O16 | |
IUPAC Name* |
methyl5-hydroxy-6-[5-hydroxy-2-(1-hydroxy-4-methoxy-2-methyl-4-oxobutyl)-2-methoxycarbonyl-4-oxo-3H-chromen-8-yl]-2-(1-hydroxy-4-methoxy-2-methyl-4-oxobutyl)-4-oxo-3H-chromene-2-carboxylate
|
|
SMILES |
COC(=O)CC(C)C(O)C1(C(=O)OC)CC(=O)c2c(ccc(-c3ccc(O)c4c3OC(C(=O)OC)(C(O)C(C)CC(=O)OC)CC4=O)c2O)O1
|
|
InChI |
InChI=1S/C34H38O16/c1-15(11-23(38)45-3)29(41)33(31(43)47-5)14-21(37)26-22(49-33)10-8-17(27(26)40)18-7-9-19(35)25-20(36)13-34(32(44)48-6,50-28(18)25)30(42)16(2)12-24(39)46-4/h7-10,15-16,29-30,35,40-42H,11-14H2,1-6H3/t15-,16-,29+,30+,33-,34-/m0/s1
|
|
InChIKey |
OGFFZWBRZKFONE-NHHXLWFISA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 702.66 | ALogp: | 1.6 |
HBD: | 4 | HBA: | 16 |
Rotatable Bonds: | 11 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 238.7 | Aromatic Rings: | 4 |
Heavy Atoms: | 50 | QED Weighted: | 0.194 |
Caco-2 Permeability: | -5.434 | MDCK Permeability: | 0.00001360 |
Pgp-inhibitor: | 0.37 | Pgp-substrate: | 0.297 |
Human Intestinal Absorption (HIA): | 0.919 | 20% Bioavailability (F20%): | 0.01 |
30% Bioavailability (F30%): | 0.976 |
Blood-Brain-Barrier Penetration (BBB): | 0.063 | Plasma Protein Binding (PPB): | 76.16% |
Volume Distribution (VD): | 0.471 | Fu: | 17.79% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.627 |
CYP2C19-inhibitor: | 0.033 | CYP2C19-substrate: | 0.276 |
CYP2C9-inhibitor: | 0.143 | CYP2C9-substrate: | 0.372 |
CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.166 |
CYP3A4-inhibitor: | 0.875 | CYP3A4-substrate: | 0.642 |
Clearance (CL): | 10.375 | Half-life (T1/2): | 0.252 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.836 |
Drug-inuced Liver Injury (DILI): | 0.968 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.838 | Maximum Recommended Daily Dose: | 0.029 |
Skin Sensitization: | 0.004 | Carcinogencity: | 0.03 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.007 |
Respiratory Toxicity: | 0.006 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005737 | 0.887 | D0T5XN | 0.255 | ||||
ENC005727 | 0.692 | D07IPB | 0.242 | ||||
ENC003346 | 0.665 | D0Q0PR | 0.240 | ||||
ENC005729 | 0.650 | D01UBX | 0.231 | ||||
ENC005732 | 0.620 | D01XWG | 0.222 | ||||
ENC005735 | 0.620 | D01XDL | 0.221 | ||||
ENC005730 | 0.613 | D03KIA | 0.219 | ||||
ENC003347 | 0.604 | D0C9XJ | 0.218 | ||||
ENC005736 | 0.580 | D07VLY | 0.218 | ||||
ENC005734 | 0.563 | D08FPM | 0.218 |